Multidisciplinary Search
Multidisciplinary Multidisciplinary
Most Read Articles
Benralizumab may help reduce OCS reliance in asthma
Roshini Claire Anthony, 18 Mar 2021

Patients with asthma reliant on oral corticosteroids (OCS) may be able to gradually cease or reduce their OCS dose after initiating treatment with benralizumab, according to results of the phase IIIb PONENTE* trial.
RAS inhibitors help prevent adverse cardiovascular outcomes after CABG
6 days ago
Renin-angiotensin system (RAS) inhibitors appear to protect against major adverse cardiovascular events after coronary artery bypass grafting (CABG), whether or not patients had an indication for treatment, a recent study has shown.
Trimetazidine new formulation redefining angina control in daily practice
12 Mar 2021
Chronic coronary syndrome (CCS) remains a leading cause of death and disability worldwide. The dual goals of CCS management is to prevent future cardiac events, such as myocardial infarction and death, and to reduce ischaemia and relieve angina symptoms, says Prof Peter Yan, consultant cardiologist and medical director, Peter Yan Cardiology Clinic, Gleneagles Medical Centre, Singapore, during a Servier-sponsored virtual symposium.
Management of MDROs in the ICU and the role of newer antimicrobial agents
Prof. David Paterson, 30 Mar 2021
Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.

PM2.5: อันตราย และการคัดเลือกหน้ากากที่มีประสิทธิภาพในการป้องกัน

Prof Dr. Orapan Poachanukoon
MD, PhD.,
26 Mar 2021
มลพิษทางอากาศจาก Particulate Matters 2.5 (PM2.5) เป็นอันตรายต่อสุขภาพของประชากรทั่วโลก รวมทั้งประเทศไทย และนับวันมลพิษทางอากาศจาก PM2.5 ก็จะทวีความรุนแรงมากขึ้น ซึ่งส่งผลกระทบต่อสุขภาพจากการสัมผัสทั้งในระยะสั้นและระยะยาว วิธีการป้องกันการเกิดเหตุการณ์อันไม่พึงประสงค์จาก PM2.5 ที่ดีที่สุด คือ “การหลีกเลี่ยงการสัมผัส” หากจำเป็นต้องสัมผัส PM2.5 โดยไม่สามารถหลีกเลี่ยงได้ แนะนำให้ใช้วิธีป้องกันการสัมผัส PM2.5 ที่มีประสิทธิภาพ เช่น การสวมใส่หน้ากากอนามัยที่มีประสิทธิภาพป้องกัน PM2.5 เป็นต้น
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Benralizumab may help reduce OCS reliance in asthma
Roshini Claire Anthony, 18 Mar 2021

Patients with asthma reliant on oral corticosteroids (OCS) may be able to gradually cease or reduce their OCS dose after initiating treatment with benralizumab, according to results of the phase IIIb PONENTE* trial.
RAS inhibitors help prevent adverse cardiovascular outcomes after CABG
6 days ago
Renin-angiotensin system (RAS) inhibitors appear to protect against major adverse cardiovascular events after coronary artery bypass grafting (CABG), whether or not patients had an indication for treatment, a recent study has shown.
Trimetazidine new formulation redefining angina control in daily practice
12 Mar 2021
Chronic coronary syndrome (CCS) remains a leading cause of death and disability worldwide. The dual goals of CCS management is to prevent future cardiac events, such as myocardial infarction and death, and to reduce ischaemia and relieve angina symptoms, says Prof Peter Yan, consultant cardiologist and medical director, Peter Yan Cardiology Clinic, Gleneagles Medical Centre, Singapore, during a Servier-sponsored virtual symposium.
Management of MDROs in the ICU and the role of newer antimicrobial agents
Prof. David Paterson, 30 Mar 2021
Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.